Value-Based Cancer Care

Abstract

Interview with Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices. (08:22)Download In the face of the growing cost of cancer care, the American Society of Clinical Oncology has published a proposed framework for assessing the value of cancer treatments, aiming to help physicians evaluate regimens on the basis of clinical benefit, toxicity, and cost.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 80 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.